Successful treatment of pediatric post-liver transplant kaposi’s sarcoma with paclitaxel
Turkish Journal of Pediatrics, cilt.62, sa.5, ss.858-862, 2020 (SCI-Expanded, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 62 Sayı: 5
- Basım Tarihi: 2020
- Doi Numarası: 10.24953/turkjped.2020.05.020
- Dergi Adı: Turkish Journal of Pediatrics
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.858-862
- Anahtar Kelimeler: Kaposi's sarcoma, children, paclitaxel
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background. Kaposi’s sarcoma (KS) is a complication of immunosuppressive therapy for transplant recipients. Unlike adult recipients, KS in pediatric organ transplantation is quite rare. Treatment is usually withdrawal of immunosuppression; non-responders often receive chemotherapy. Case. We have reported a child with post-liver transplant visceral KS which has progressed despite withdrawal of immunosuppressive therapy, who has been treated with Paclitaxel for three weeks. KS has regressed completely after four cycles of Paclitaxel. Conclusion. Paclitaxel should be considered as an effective first line treatment option for patients with post-transplant KS.